{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-24-000020","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2024-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.947543+00:00","generated_at":"2026-06-04T07:54:59.835050+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"vTv Therapeutics regains Nasdaq MVLS compliance; listing continues","bullets":["Nasdaq notified vTv Therapeutics on March 25, 2024 that it regained compliance with the $35M MVLS minimum.","Common stock ticker VTVT will continue listing on the Nasdaq Capital Market.","No further deficiency actions required; prior MVLS concern resolved."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-24-000020","json":"https://secwatch.observer/filing/0001641489-24-000020.json","markdown":"https://secwatch.observer/filing/0001641489-24-000020.md","text":"https://secwatch.observer/filing/0001641489-24-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148924000020/0001641489-24-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148924000020/vtvt-20240325.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T07:54:59.835050+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}